Nasdaq confirmed POMDOCTOR regained compliance with its minimum bid price requirement after shares traded at or above $1.00 for 10 days.
POMDOCTOR (NASDAQ:POM) announced Nasdaq confirmed its compliance with the $1 minimum bid price requirement on July 10. The company’s American depositary shares closed at or above $1.00 for 10 consecutive business days from June 25 to July 9.
The compliance follows Nasdaq Listing Rule 5450(a)(1), which mandates a minimum bid price for continued listing. Shares fell 7.27% in recent trading, reflecting investor reaction to the regulatory update.
No immediate market reaction details were provided beyond the price movement.